Rogstad et al., 2009 - Google Patents

Chemical decomposition of 5-aza-2′-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry

Rogstad et al., 2009

View HTML
Document ID
14226780571776840670
Author
Rogstad D
Herring J
Theruvathu J
Burdzy A
Perry C
Neidigh J
Sowers L
Publication year
Publication venue
Chemical research in toxicology

External Links

Snippet

The nucleoside analogue 5-aza-2′-deoxycytidine (Decitabine, DAC) is one of several drugs in clinical use that inhibit DNA methyltransferases, leading to a decrease of 5- methylcytosine in newly replicated DNA and subsequent transcriptional activation of genes …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Rogstad et al. Chemical decomposition of 5-aza-2′-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry
Pappalardi et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
Parker Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer
Hocek et al. Synthesis and cytostatic activity of substituted 6-phenylpurine bases and nucleosides: application of the Suzuki− Miyaura cross-coupling reactions of 6-chloropurine derivatives with phenylboronic acids
Van Daele et al. Rational Design of 5 ‘-Thiourea-Substituted α-Thymidine Analogues as Thymidine Monophosphate Kinase Inhibitors Capable of Inhibiting Mycobacterial Growth
Wu et al. Gas-phase conformations and energetics of protonated 2′-deoxyadenosine and adenosine: IRMPD action spectroscopy and theoretical studies
Catalano et al. Chemical structure and properties of interstrand cross-links formed by reaction of guanine residues with abasic sites in duplex DNA
Kistemaker et al. Stereoselective ribosylation of amino acids
Parmenopoulou et al. Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation
Hattori et al. Nucleosides and Nucleotides. 175. Structural Requirements of the Sugar Moiety for the Antitumor Activities of New Nucleoside Antimetabolites, 1-(3-C-Ethynyl-β-d-r ibo-pentofuranosyl) cytosine and-uracil
Ko et al. Structure− Activity Relationship of Uridine 5 ‘-Diphosphoglucose Analogues as Agonists of the Human P2Y14 Receptor
Lee et al. Synthesis and structure of duplex DNA containing the genotoxic nucleobase lesion N7-methylguanine
Zhu et al. Influence of sodium cationization versus protonation on the gas-phase conformations and glycosidic bond stabilities of 2′-deoxyadenosine and adenosine
Brown et al. Unraveling the aflatoxin− FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1
Hassan et al. Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: Palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides
WO2017114796A1 (en) Adenosylhomocysteinase binding substances for medical use
Kistemaker et al. Branching of poly (ADP-ribose): Synthesis of the Core Motif
D’Onofrio et al. Synthesis, biophysical characterization, and anti-HIV activity of glyco-conjugated G-quadruplex-forming oligonucleotides
Eletskaya et al. Enzymatic synthesis of novel purine nucleosides bearing a chiral benzoxazine fragment
Moreau et al. Structural Determinants for N1/N7 Cyclization of Nicotinamide Hypoxanthine 5 ‘-Dinucleotide (NHD+) Derivatives by ADP-Ribosyl Cyclase from Aplysia californica: Ca2+-Mobilizing Activity of 8-Substituted Cyclic Inosine 5 ‘-Diphosphoribose Analogues in T-Lymphocytes
Chatzileontiadou et al. Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin
Van Poecke et al. 3′-[4-Aryl-(1, 2, 3-triazol-1-yl)]-3′-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase
Mehellou et al. Design, synthesis, and anti-HIV activity of 2′, 3′-didehydro-2′, 3′-dideoxyuridine (d4U), 2′, 3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’derivatives
Robins et al. Inactivation of S-Adenosyl-l-homocysteine Hydrolase and Antiviral Activity with 5 ‘, 5 ‘, 6 ‘, 6 ‘-Tetradehydro-6 ‘-deoxy-6 ‘-halohomoadenosine Analogues (4 ‘-Haloacetylene Analogues Derived from Adenosine)
Cao et al. Stereospecific Synthesis and Characterization of Oligodeoxyribonucleotides Containing an N 2-(1-Carboxyethyl)-2 ‘-deoxyguanosine